EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Liraglutide Hospital Discharge Trial

Phase 4

Completed

Conditions: Type 2 Diabetes

Interventions: Drug: Liraglutide + OADs
Drug: Glargine + OADs

First Posted Date: 2013-08-09

Last Posted Date: 2021-11-03

Lead Sponsor: Emory University

Target Recruit Count: 273

Registration Number: NCT01919489

Locations: 🇺🇸
Emory Universtiy Hospital at MIdtown, Atlanta, Georgia, United States
🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

and more 2 locations

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

Phase 1

Completed

Conditions: Hurler Syndrome
Fanconi Anemia
Glanzmann Thrombasthenia
Wiskott-Aldrich Syndrome
Chronic Granulomatous Disease
Severe Congenital Neutropenia
Leukocyte Adhesion Deficiency
Shwachman-Diamond Syndrome
Diamond-Blackfan Anemia
Dyskeratosis-congenita

Interventions: Drug: Abatacept

First Posted Date: 2013-08-07

Last Posted Date: 2019-12-26

Lead Sponsor: Emory University

Target Recruit Count: 10

Registration Number: NCT01917708

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda

Not Applicable

Completed

Conditions: HIV
Acquired Immunodeficiency Syndrome
Influenza

Interventions: Drug: Seasonal trivalent inactivated influenza vaccine (Vaxigrip®)

First Posted Date: 2013-08-06

Last Posted Date: 2014-04-23

Lead Sponsor: Emory University

Target Recruit Count: 63

Registration Number: NCT01916759

Locations: 🇺🇬
Makere University- Johns Hopkins University Research Collaboration, at the Mulago National Referral Hospital, Kampala, Uganda

Effects of Treatment on Decision-making in Major Depression

Phase 4

Completed

Conditions: Major Depressive Disorder
Healthy Controls

Interventions: Drug: Any FDA Approved Antidepressant

First Posted Date: 2013-08-06

Last Posted Date: 2017-11-21

Lead Sponsor: Emory University

Target Recruit Count: 53

Registration Number: NCT01916824

Locations: 🇺🇸
Emory Mood and Anxiety Disorders Program, Atlanta, Georgia, United States

Two Vitamin D Dosing Strategies in Children With Chronic Kidney Disease

Phase 1

Completed

Conditions: Chronic Kidney Disease

Interventions: Drug: 1000 IU of Vitamin D3
Drug: 4000 IU of Vitamin D3

First Posted Date: 2013-07-26

Last Posted Date: 2020-05-19

Lead Sponsor: Emory University

Target Recruit Count: 98

Registration Number: NCT01909115

Locations: 🇺🇸
Childen's Healthcare of Atlanta, Atlanta, Georgia, United States

A Web-based Bystander Education Program

Not Applicable

Completed

Conditions: Sexual Violence

Interventions: Behavioral: Bystander & Sexual Violence Prevention
Behavioral: General Health Promotion

First Posted Date: 2013-07-19

Last Posted Date: 2014-07-23

Lead Sponsor: Emory University

Target Recruit Count: 743

Registration Number: NCT01903876

Locations: 🇺🇸
Georgia State University, Atlanta, Georgia, United States

Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis

Phase 4

Withdrawn

Conditions: Lymphatic Filariasis
Trachoma

Interventions: Drug: azithromycin
Drug: ivermectin
Drug: albendazole
Drug: placebo

First Posted Date: 2013-07-19

Last Posted Date: 2014-05-22

Lead Sponsor: Emory University

Registration Number: NCT01903057

Locations: 🇲🇿
National Institute of Health, Ministry of Health, Maputo, Mozambique

Antibiotics and Tissue Expanders in Breast Reconstruction

Phase 4

Withdrawn

Conditions: Complications; Breast Prosthesis, Infection or Inflammation

Interventions: Drug: antibiotic

First Posted Date: 2013-07-15

Last Posted Date: 2017-02-24

Lead Sponsor: Emory University

Registration Number: NCT01899690

Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)

Phase 3

Terminated

Conditions: Epilepsy, Partial
Epilepsy, Localization Related

Interventions: Drug: Levetiracetam
Drug: Lamotrigine
Drug: Oxcarbazepine

First Posted Date: 2013-07-03

Last Posted Date: 2017-09-19

Lead Sponsor: Emory University

Target Recruit Count: 72

Registration Number: NCT01891890

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸
Cincinnati Children's Hospital, Cincinnati, Ohio, United States

and more 11 locations

A Mobile Personal Health Record for Behavioral Health Homes

Not Applicable

Completed

Conditions: Diabetes
Hyperlipidemia
Hypertension

Interventions: Behavioral: Mobile Personal Health Record App.

First Posted Date: 2013-07-01

Last Posted Date: 2020-02-17

Lead Sponsor: Emory University

Target Recruit Count: 311

Registration Number: NCT01890226

Locations: 🇺🇸
Viewpoint Health & Oakhurst Medical Center, Conyers, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy